Medical Device News Magazine


Surgeons Help Create New Process for Disinfecting and Reusing N95 Masks

This approach, according to the authors, increased employee acceptance of reusing what is normally a single-use N95 mask and helped ensure proper fit of the returned mask.

JVIR, SIR Foundation Honor Best Research Published in 2019

The annual awards, supported by SIR Foundation, were chosen by the editor after a comprehensive editorial board review of all papers submitted to JVIR during the prior year.

Recommendations for Resumption of Elective Endoscopy During the COVID-19 Pandemic

As new COVID-19 diagnosis rates plateau in certain communities around the U.S. and federal, state and local authorities permit the reopening of health care facilities, resumption of elective endoscopy activity is appropriate.

ACEP Announces Susan Sedory as its Next Executive Director

Ms. Sedory will be ACEP's fourth executive director—and first female in this position—in the College's more than 50-year history.

Feed the Children Goes Coast to Coast Feeding Hungry Children

Feed the Children has been working with its network of community partners on the ground in cities and towns across the U.S. and in the 10 countries it serves to address the ever-growing needs of those affected by COVID-19.

Clinical Considerations for Resuming Elective Surgery Released by The American Academy of Orthopaedic Surgeons

American Academy of Orthopaedic Surgeons notes the considerations, which include five guiding principles, come as the Centers for Medicare and Medicaid Services ssued recommendations for re-opening America’s Health Care Systems.

Recent News

Study: Private Equity Acquisitions in Cardiology on the Rise

“Policymakers and clinicians have raised concern about the growing presence of private equity in other medical specialties. Although cardiology is an attractive target for private equity firms, little is known about the number and types of practices that are being acquired,” said Senior Author Rishi K. Wadhera, MD, MPP, MPhil, a cardiologist at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School in Boston. “Private equity acquisitions in other specialties have been shown to decrease quality and increase costs, so it is critical to understand the impact on cardiology.”

CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A

"Collaborating with ReviR Therapeutics aligns perfectly with CMTRF's mission to accelerate the development of therapies that can halt or even reverse the progression of CMT," says Cleary Simpson, CEO of the CMT Research Foundation. "Their cutting-edge technology has the potential to transform the lives of those living with this chronic condition by providing a non-invasive, potent, and easily administrable treatment option."